eMagin Files Form 10K for 2005
April 17 2006 - 5:07PM
Business Wire
On March 27, 2006 eMagin Corporation (AMEX:EMA) announced
preliminary results for the fiscal year ended December 31, 2005 and
during its earnings call acknowledged that it would complete a
12b-25 filing, stating that the company would need additional time
to file its Annual Report. The filing was completed on April 17,
2006 and is deemed timely. The audited results contained no
material differences between preliminary figures and eMagin
reconfirms its comfort with revenue projections of $1.5 million to
$1.9 million for the first quarter ended March 31, 2006. In
addition, in compliance with American Stock Exchange Company Guide
Section 610(b), the company would like to highlight that its
independent registered public accounting firm included a going
concern explanatory paragraph in its report on eMagin's
consolidated financial statements as of and for the year ended
December 31, 2005 due to its prior losses and expected cash
requirements. eMagin is targeting revenue of approximately $20
million for its current fiscal year, which represents an increase
of over 400% as compared to 2005. To accomplish this growth will
require approximately $9 million of working capital to support
projected higher accounts receivable and inventory levels;
additional amounts may also be required for operations or capital
equipment purchases. At December 31, 2005 eMagin had negligible
long term debt and a cash balance of $6.8 million. Management's
intent is to address the company's additional funding requirement
through the addition of debt as well as improved operating
efficiencies or lower expenses if required. About eMagin
Corporation A leader in OLED microdisplay and virtual imaging
technologies, eMagin integrates high-resolution OLED microdisplays,
magnifying optics, and systems technologies to create a virtual
image that appears comparable to that of a computer monitor or a
large-screen television. eMagin's OLED displays have broad market
reach and are incorporated into a variety of near-to-eye imaging
products by military, industrial, medical and consumer OEMs who
choose eMagin's award-winning technology as a core component for
their solutions. eMagin has recently introduced its first
direct-to-consumer system, the Z800 3DVisor, which provides superb
3D stereovision and headtracking for PC gaming, training and
simulation, and business applications. eMagin's microdisplay
manufacturing and R&D operations are co-located with IBM on its
campus in East Fishkill, New York. System design facilities and
sales and marketing are located in Bellevue, Washington. A sales
office is located in Tokyo, Japan. For additional information,
please visit www.emagin.com and www.3dvisor.com. Note: eMagin is a
trademark of eMagin Corporation. Forward Looking Statements This
press release contains forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Exchange Act of 1934, including those
regarding eMagin Corporation and its subsidiaries' expectations,
intentions, strategies and beliefs pertaining to future events or
future financial performance. All statements contained herein are
based upon information available to eMagin's management as of the
date hereof, and actual results may vary based upon future events,
both within and without eMagin management's control. In some cases,
you can identify forward-looking statements by terminology such as
"may," "will," "should," "expect," "plan," "anticipate," "believe,"
"estimate," "predict," "potential" or "continue," the negative of
such terms, or other comparable terminology. These statements are
only predictions. Actual events or results may differ materially
from those in the forward-looking statements as a result of various
important factors, including those described in the Company's most
recent filings with the SEC. Although we believe that the
expectations reflected in the forward-looking statements are
reasonable, such statements should not be regarded as a
representation by the Company, or any other person, that such
forward-looking statements will be achieved. The business and
operations of the Company are subject to substantial risks which
increase the uncertainty inherent in forward-looking statements. We
undertake no duty to update any of the forward-looking statements,
whether as a result of new information, future events or otherwise.
In light of the foregoing, readers are cautioned not to place undue
reliance on such forward-looking statements.
Emagin (AMEX:EMA)
Historical Stock Chart
From Nov 2024 to Dec 2024
Emagin (AMEX:EMA)
Historical Stock Chart
From Dec 2023 to Dec 2024